Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 83% ± 15% | |
lung | 19 studies | 73% ± 18% | |
brain | 16 studies | 45% ± 20% | |
intestine | 14 studies | 66% ± 24% | |
kidney | 9 studies | 72% ± 19% | |
eye | 9 studies | 54% ± 21% | |
liver | 8 studies | 55% ± 26% | |
lymph node | 7 studies | 83% ± 9% | |
bone marrow | 6 studies | 71% ± 24% | |
uterus | 6 studies | 70% ± 28% | |
pancreas | 5 studies | 73% ± 23% | |
prostate | 5 studies | 62% ± 32% | |
placenta | 4 studies | 75% ± 25% | |
heart | 4 studies | 35% ± 17% | |
breast | 4 studies | 85% ± 7% | |
ovary | 3 studies | 49% ± 15% | |
adipose | 3 studies | 42% ± 29% | |
adrenal gland | 3 studies | 73% ± 19% | |
esophagus | 3 studies | 71% ± 13% | |
skin | 3 studies | 72% ± 13% | |
stomach | 3 studies | 44% ± 22% | |
thymus | 3 studies | 81% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 29093.09 | 1445 / 1445 | 100% | 378.33 | 183 / 183 |
intestine | 100% | 38068.26 | 966 / 966 | 100% | 528.84 | 527 / 527 |
ovary | 100% | 16696.26 | 180 / 180 | 100% | 489.75 | 430 / 430 |
skin | 100% | 35002.82 | 1809 / 1809 | 100% | 452.44 | 472 / 472 |
uterus | 100% | 29840.95 | 170 / 170 | 100% | 450.78 | 459 / 459 |
brain | 100% | 30914.80 | 2640 / 2642 | 100% | 412.56 | 705 / 705 |
thymus | 100% | 20416.45 | 652 / 653 | 100% | 299.54 | 604 / 605 |
stomach | 100% | 22530.96 | 359 / 359 | 100% | 499.39 | 285 / 286 |
bladder | 100% | 26374.38 | 21 / 21 | 100% | 506.82 | 502 / 504 |
kidney | 100% | 26326.39 | 89 / 89 | 99% | 224.62 | 896 / 901 |
prostate | 100% | 23908.58 | 244 / 245 | 100% | 308.64 | 501 / 502 |
breast | 100% | 26685.64 | 459 / 459 | 99% | 408.27 | 1110 / 1118 |
lung | 100% | 35009.32 | 577 / 578 | 99% | 385.27 | 1147 / 1155 |
adrenal gland | 100% | 21551.24 | 258 / 258 | 96% | 213.60 | 221 / 230 |
liver | 96% | 13172.57 | 216 / 226 | 100% | 206.19 | 405 / 406 |
pancreas | 78% | 7196.66 | 256 / 328 | 99% | 425.16 | 177 / 178 |
adipose | 100% | 28633.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 342.20 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 677.28 | 29 / 29 |
spleen | 100% | 39028.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 433.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1115.81 | 1 / 1 |
blood vessel | 100% | 35432.55 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 63653.36 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 15886.19 | 836 / 861 | 0% | 0 | 0 / 0 |
muscle | 75% | 6429.40 | 601 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030042 | Biological process | actin filament depolymerization |
GO_0022604 | Biological process | regulation of cell morphogenesis |
GO_0009615 | Biological process | response to virus |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0044794 | Biological process | positive regulation by host of viral process |
GO_0051293 | Biological process | establishment of spindle localization |
GO_0040019 | Biological process | positive regulation of embryonic development |
GO_0051014 | Biological process | actin filament severing |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0061001 | Biological process | regulation of dendritic spine morphogenesis |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030043 | Biological process | actin filament fragmentation |
GO_0007266 | Biological process | Rho protein signal transduction |
GO_0032587 | Cellular component | ruffle membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005925 | Cellular component | focal adhesion |
GO_0016363 | Cellular component | nuclear matrix |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0031258 | Cellular component | lamellipodium membrane |
GO_0005829 | Cellular component | cytosol |
GO_0030426 | Cellular component | growth cone |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0031982 | Cellular component | vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CFL1 |
Protein name | Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform) Cofilin-1 (Cofilin, non-muscle isoform) |
Synonyms | hCG_2039457 CFL |
Description | FUNCTION: Binds to F-actin and exhibits pH-sensitive F-actin depolymerizing activity . In conjunction with the subcortical maternal complex (SCMC), plays an essential role for zygotes to progress beyond the first embryonic cell divisions via regulation of actin dynamics . Required for the centralization of the mitotic spindle and symmetric division of zygotes (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization in epithelial cells . Required for the up-regulation of atypical chemokine receptor ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation . Required for neural tube morphogenesis and neural crest cell migration (By similarity). . |
Accessions | ENST00000308162.10 ENST00000534769.5 E9PQB7 E9PS23 ENST00000524553.5 ENST00000527344.5 E9PK25 E9PLJ3 ENST00000532134.5 ENST00000530413.1 G3V1A4 ENST00000525451.6 E9PP50 ENST00000526975.1 ENST00000531407.5 P23528 ENST00000531413.5 ENST00000534784.1 |